Table 1.
Formal NRs involved in drug metabolism and disposition | |||
---|---|---|---|
NR | Major gene types regulated | Effects upon induction | Key ligands and types |
PXR | CYPs, UGTs, GST, SULTs, MDR, MRP, OATs | Detoxification and biotransformation of xenobiotics, regulation of homeostasis | Various drug, drug-like, and endobiotic compounds |
CAR | CYPs, UGTs, GST, SULTs, MDR, MRP, OATs | Detoxification and biotransformation of xenobiotics, regulation of homeostasis | Small-molecule compounds |
FXRa | CYPs, UGTs, SULTs, MRP, OATs, MDR, SHP, PPAR, PXR | Bile acid and lipid homeostasis, bile acid export and regulation of bile acid formation | Cholesterol-based compounds, farnesol metabolites, bile acid metabolites |
VDR | CYPs, SULTs, MRP, FXR | Calcium homeostasis, cell proliferation and differentiation | 1α,25-dihydroxyvitamin D3, LCA |
HNF4αb | CYPs, SULTs, MDR, OATs, PXR, CAR, PPAR, FXR | Liver development, lipid and bile metabolism, bile acid synthesis | Fatty acids, linoleic acid |
PPAR | CYPs, UGTs, GSTs, SULTs, MDR, FXR, SHP | Fatty acid homeostasis, repression of bile acid synthesis, inflammation | Fatty acids, thiazolidinediones, hypolipidemic fibrates |
GRb | CYPs, MRP, CAR, PXR, RXRα | Immunoresponse, stimulation of bile acid transport | Glucocorticoids |
LXR | SULTs | Regulation of cholesterol synthesis and absorption, modulation of bile acid toxicity and cholestasis | Cholesterol-based compounds (oxysterols) |
RORb | CYPs, SULTs, GSTs | Triglyceride regulation, glucose homeostasis | Cholesterol, retinoic acids, melatonin, thiazolidindiones |
RXR | Dependent on binding Partner | Dependent on binding partner | Retinoic acids |
Atypical NR-like proteins involved in drug metabolism and disposition | |||
---|---|---|---|
Receptor | Major genes regulated | Effects upon induction | Key ligands and types |
AhR | CYPs, GSTs, UGTs, MRP, SULTs | Cell-cycle control, metabolic adaptation to xenobiotics, chemical toxicity signals | Polycyclic aromatic hydrocarbons, halogenated aromatic hydrocarbons |
SHP | AR, ER, HNF4, LRH-1, LXR, PPAR, RAR, RXR, and other NRs | Repression of NRs through heterodimerization | Small, synthetic molecules, others unknown |
Nrf2 | GSTs, UGTs, SULTs, MRP, AhR | Protection against oxidative and electrophilic stress | — |
Detailed for each NR (top) are the major gene types regulated, the observed effects upon receptor activation, and some of the known ligands and ligand types. Further outlined are atypical and receptor-like proteins (bottom) that have been identified as modulators of drug metabolism and formal NRs with direct effects on gene regulation. For these informal receptors, the major genes and proteins regulated, the observed effects, and key ligand types are given.
Can function with or without RXRα.
Functions as monomer or homodimer.